T0	Participants 24 32	Finland:
T1	Participants 62 107	prostate, breast, and colorectal cancer risk.
T2	Participants 497 502	Finns
T3	Participants 535 592	more than 4,000 prostate cancer cases and 5,000 controls.
T4	Participants 593 675	In addition, 986 breast cancer and 442 colorectal cancer (CRC) cases were studied.
T5	Participants 1690 1712	the Finnish population
T6	Participants 1759 1768	and cases
T7	Participants 1871 1898	mutation in prostate cancer